1. Home
  2. MSM vs MIRM Comparison

MSM vs MIRM Comparison

Compare MSM & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MSC Industrial Direct Company Inc.

MSM

MSC Industrial Direct Company Inc.

N/A

Current Price

$90.27

Market Cap

5.2B

Sector

Industrials

ML Signal

N/A

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

N/A

Current Price

$88.62

Market Cap

5.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSM
MIRM
Founded
1941
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.4B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
MSM
MIRM
Price
$90.27
$88.62
Analyst Decision
Hold
Strong Buy
Analyst Count
5
12
Target Price
$91.00
$114.67
AVG Volume (30 Days)
489.6K
641.3K
Earning Date
04-08-2026
05-18-2026
Dividend Yield
3.81%
N/A
EPS Growth
N/A
74.59
EPS
0.93
N/A
Revenue
$3,363,817,000.00
$19,138,000.00
Revenue This Year
$5.96
$24.61
Revenue Next Year
$5.23
$21.75
P/E Ratio
$98.27
N/A
Revenue Growth
4.99
N/A
52 Week Low
$68.10
$36.88
52 Week High
$96.99
$109.28

Technical Indicators

Market Signals
Indicator
MSM
MIRM
Relative Strength Index (RSI) 45.17 40.14
Support Level $82.32 $72.17
Resistance Level $93.15 $107.51
Average True Range (ATR) 2.38 4.14
MACD -0.60 -2.22
Stochastic Oscillator 39.08 12.14

Price Performance

Historical Comparison
MSM
MIRM

About MSM MSC Industrial Direct Company Inc.

Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: